GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (FRA:9VC) » Definitions » Pretax Margin %

ATAI Life Sciences NV (FRA:9VC) Pretax Margin % : % (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is ATAI Life Sciences NV Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. ATAI Life Sciences NV's Pre-Tax Income for the three months ended in Mar. 2024 was €-23.63 Mil. ATAI Life Sciences NV's Revenue for the three months ended in Mar. 2024 was €0.00 Mil. Therefore, ATAI Life Sciences NV's pretax margin for the quarter that ended in Mar. 2024 was %.

The historical rank and industry rank for ATAI Life Sciences NV's Pretax Margin % or its related term are showing as below:

FRA:9VC' s Pretax Margin % Range Over the Past 10 Years
Min: -58018.03   Med: -12511.46   Max: -670.4
Current: -11484.48


FRA:9VC's Pretax Margin % is ranked worse than
91.95% of 1019 companies
in the Biotechnology industry
Industry Median: -154.52 vs FRA:9VC: -11484.48

ATAI Life Sciences NV Pretax Margin % Historical Data

The historical data trend for ATAI Life Sciences NV's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ATAI Life Sciences NV Pretax Margin % Chart

ATAI Life Sciences NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
- - -670.39 -58,005.45 -12,508.68

ATAI Life Sciences NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -88,480.00 -18,377.36 50,103.66 -98,817.65 -

Competitive Comparison of ATAI Life Sciences NV's Pretax Margin %

For the Biotechnology subindustry, ATAI Life Sciences NV's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ATAI Life Sciences NV's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ATAI Life Sciences NV's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where ATAI Life Sciences NV's Pretax Margin % falls into.



ATAI Life Sciences NV Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

ATAI Life Sciences NV's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-36.025/0.288
=-12,508.68 %

ATAI Life Sciences NV's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-23.627/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ATAI Life Sciences NV  (FRA:9VC) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


ATAI Life Sciences NV Pretax Margin % Related Terms

Thank you for viewing the detailed overview of ATAI Life Sciences NV's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


ATAI Life Sciences NV (FRA:9VC) Business Description

Traded in Other Exchanges
Address
Wallstraße 16, Berlin, BB, DEU, 10179
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

ATAI Life Sciences NV (FRA:9VC) Headlines

No Headlines